UNSPSC 51293401: Cirazoline
Commodity
Code facts
- Part of
-
-
51000000
-
51290000
- 51293400
-
51290000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51293401
Definition
This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QK318GVY3Y, chemically known as 1h-imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-, monohydrochloride but generally known as cirazoline, which bears US NIH Compound Identifier 2765. European Medicines Agency schedules Cirazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07478MIG.
Read the full definition
The term CIRAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CIRAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cirazoline under HS 29332990 and SITC 51573. As of Q4 2014, CIRAZOLINE remains the US FDA Preferred Term for this commodity. Cirazoline bears US NLM identifiers UMLS ID C0109817 and NCI Concept Code C77294. SMILES: O(c1c(C2CC2)cccc1)CC1=NCCN1.
About UNSPSC 51293401
UNSPSC 51293401 Cirazoline is a Commodity code that in practice covers pharmaceutical products supplied to state and local health agencies and community health programs. Recent solicitations show state and local governments purchasing naloxone and drug deactivation systems for public health initiatives, generic multi-source pharmaceuticals for distribution across government facilities, and exploring direct-to-manufacturer prescription fulfillment models through pharmacy benefit programs. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. The work involves product sourcing, compliance with cGMP and Drug Supply Chain Security Act standards, coordination with authorized pharmaceutical wholesalers, and quarterly or ongoing delivery to designated health facilities.
Activity spans Florida, Minnesota, Oregon, and Texas, with recent opportunities including Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026), and the Texas Health and Human Services Commission's RFI regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program (HHS0017013, posted April 3, 2026). Vendors in this space must maintain wholesaler relationships, comply with NDC coding requirements, carry appropriate insurance coverage including commercial general liability and professional liability coverage, and demonstrate pricing flexibility through multiple net pricing formats. Contracts typically run two years with optional renewals and often include administrative fees or performance penalties tied to compliance metrics.
Quick answers
What is UNSPSC 51293401?
UNSPSC 51293401 is Cirazoline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51293401?
UNSPSC 51293401 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51293401
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code